SCHEMBL1387236

SCHEMBL1387236

CN(C)c1ccc(Nc2cc(Nc3ccc(F)c(Cl)c3)ncn2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.66
MAPK1 P28482 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
USP2 O75604 1/20 0.57
ALDH1A1 P00352 1/20 0.57
TP53 P04637 1/20 0.57
CYP1A2 P05177 1/20 0.57
GLA P06280 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
ALOX15 P16050 1/20 0.57
CYP2C19 P33261 1/20 0.57
HSD17B10 Q99714 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
EGFR P00533 7/20 0.47
ERBB3 P21860 1/20 0.47
TNNI3K Q59H18 2/20 0.46
GRM1 Q13255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7775667 0.86 EGFR (0.60) MAPK1EGFRERBB3TNNI3KGRM1
SCHEMBL1387327 0.85 APP (0.62) NPC1MAPK1MEN1KMT2AEGFR
SCHEMBL8321537 0.84 NPC1 (0.47) NPC1MAPK1MEN1KMT2AUSP2
SCHEMBL7775673 0.83 EGFR (0.57) NPC1MAPK1MEN1KMT2AEGFR
SCHEMBL7771232 0.81 MEN1 (0.70) NPC1MEN1KMT2AEGFRERBB3
SCHEMBL690919 0.80 NPC1 (0.55) NPC1MAPK1EGFRERBB3GRM1
SCHEMBL7771255 0.79 EGFR (0.62) MAPK1EGFRERBB3TNNI3KGRM1
SCHEMBL1095277 0.79 MAPK1 (0.61) MAPK1EGFRERBB3GRM1FBP1
SCHEMBL7776032 0.78 EGFR (0.55) NPC1MAPK1MEN1KMT2AEGFR
SCHEMBL691545 0.78 EGFR (0.51) NPC1MAPK1MEN1KMT2AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733045-B1 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2001-08-16 EP claimed
US-5880130-A TREATMENT OF CELL-PROLIFERATION DISEASES ZENECA LIMITED (GB) 1999-03-09 US claimed
JP-H09506363-A 1997-06-24 JP claimed
EP-0733045-A1 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS ZENECA LIMITED (GB) 1996-09-25 EP claimed
WO-1995015952-A1 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS ZENECA LIMITED (GB) 1995-06-15 WO claimed
EP-0733045-B1 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2001-08-16 EP disclosed
US-5880130-A TREATMENT OF CELL-PROLIFERATION DISEASES ZENECA LIMITED (GB) 1999-03-09 US disclosed
EP-0733045-A1 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS ZENECA LIMITED (GB) 1996-09-25 EP disclosed
WO-1995015952-A1 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS ZENECA LIMITED (GB) 1995-06-15 WO disclosed